ouabain has been researched along with Pulmonary Arterial Remodeling in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Couto, GK; França-Neto, A; Rossoni, LV; Xavier, FE | 1 |
| Dong, M; Feng, YM; Hao, JP; Ji, X; Qie, LY; Shi, H; Zhang, CM; Zhang, J | 1 |
2 other study(ies) available for ouabain and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
Cyclooxygenase-2 is a critical determinant of angiotensin II-induced vascular remodeling and stiffness in resistance arteries of ouabain-treated rats.
Topics: Angiotensin II; Animals; bcl-2-Associated X Protein; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Hydrochlorothiazide; Losartan; Matrix Metalloproteinase 2; Mesenteric Arteries; Ouabain; Rats; Rats, Wistar; Reactive Oxygen Species; Vascular Remodeling; Vascular Resistance | 2022 |
Role of GSPE in improving early cerebral vascular damage by inhibition of Profilin-1 expression in a ouabain-induced hypertension model.
Topics: Animals; Blood Pressure; Grape Seed Extract; Hypertension; Male; Nitric Oxide Synthase Type III; Ouabain; Proanthocyanidins; Profilins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Vascular Remodeling | 2018 |